// App-Quantinova.ai

M1181 2016 AHA : Circulating Nucleoside and Bile Acid Intermediary Metabolites Are Associated With Recurrent Ischemic Events in Acute Coronary Syndrome

Researchers

Presenter

  • Jordan Morningstar

Principal Investigators

  • Elizabeth Grass

  • Mark Y Chan

  • Svati H Shah

  • Simon Gregory

  • Megan L Neely

  • Keith AA Fox

  • Harvey White

  • Paul Armstrong

  • E Magnus Ohman

  • Matthew Roe

  • Robert E Gerszten

Medical Centers

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

  • National Univ. of Singapore, Singapore, Singapore.

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Auckland City Hospital, Auckland, New Zealand

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Duke Medcl Ctr, Durham, NC

Locations

  • Canada

  • Singapore

  • United Kingdom

  • United States

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • intrarectal sodium taurocholate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim